Indomethacin vs. Ibuprofen for Managing Patent Ductus Arteriosus in Preterm Infants | CE493 > Continuing Education Unit at Nurse.com

FAQContact usTerms of servicePrivacy Policy

Indomethacin vs. Ibuprofen for Managing Patent Ductus Arteriosus in Preterm Infants - CE493
Indomethacin vs. Ibuprofen for Managing Patent Ductus Arteriosus in Preterm Infants

CE493 l 1.00 contact hrs
by Patricia H. White, MSN-Ed, RNC-NIC, CNE and Ashley Darcy, RN, MSN, NNP-BC and Danielle Whytal, RN, MSN, NNP-BC
Average Rating
(4.5 / 3578 reviews)
Get this course FREE with an Unlimited CE Membership


CE OVERVIEW REVIEWS     
Objectives:
The goal of this program is to provide nurses with information about indomethacin (Indocin) and ibuprofen (Motrin, Advil) as options for treating symptomatic patent ductus arteriosus in preterm infants. After studying the information presented here, you will be able to:
  • Discuss the pathophysiology and symptomatology of PDA in the preterm infant
  • Describe the risks and benefits of pharmacologic treatment options for preterm infants with symptomatic PDA
  • Explain clinician interventions for infants undergoing treatment for symptomatic PDA

 
Accreditation Information
 
This course is intended for an interprofessional audience, including nurses and EMTs/paramedics.
 
Nurses: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at www.continuingeducation.com or Nurse.com/CE. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at lms.nurse.com and search for this topic title.

This course will be updated or discontinued on or before 4/16/2018

Recommended CE

 
Late Preterm Infants Need Special Care
The goal of this continuing education program is to provide nurses with information about the incidence, etiol... More Info
Neonatal Abstinence Syndrome Off to a Shaky Start
The goal of this program is to help nurses identify the risk factors, symptoms, and nursing interventions for ... More Info
Congenital Heart Disease in the Neonate
The goal of this program is to provide nurses with an overview of fetal cardiac development, the transition of... More Info
Alarm Fatigue Can Endanger Patients
The goal of this continuing education program is to provide nurses with information about safety concerns asso... More Info


OnCourse Learning is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.

separator-ads
CE Courses
CE by Type
CE Resources